Drug search by name

Revonto and Pulmonary impairment

Result of checking the interaction of drug Revonto and disease Pulmonary impairment for safety when used together.

Check result:

Revonto <> Pulmonary impairment

Relevance: 23.07.2019 Reviewer: Shkutko P.M., M.D., in

When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.

Consumer:

Dantrolene may cause respiratory depression that is possibly related to the muscle weakness produced by the drug. Pleural effusion associated with pericarditis has also occurred occasionally during the long-term administration of dantrolene. Therapy with dantrolene should be administered cautiously in patients with impaired pulmonary function, particularly that due to obstructive pulmonary disease. Patients who receive intravenous dantrolene should have vital signs monitored.

References:

Miller DH, Haas LF "Pneumonitis with dantrolene." J Neurol Neurosurg Psychiatry 47 (1984): 553-4
"Product Information. Dantrium (dantrolene)." Procter and Gamble Pharmaceutic, Cincinnati, OH.
Petusevsky ML, Faling LJ, Rocklin RE, Snider GL, Merliss AD, Moses JM, Dorman SA "Pleuropericardial reaction to treatment with dantrolene." JAMA 242 (1979): 2772-4

Revonto

Generic Name: dantrolene

Brand Name: Dantrium, Revonto, Dantrium Intravenous, Ryanodex

Synonyms: Revonto Injection

What is Revonto?